Garrett, T. E., Chekmasova, A. A., Evans, J. W., Seidel, S. L., Horton, H. M., Latimer, H. J., . . . Morgan, R. A. (2015). A BCMA-specific CAR T cell produced with clinically scalable lentiviral and T cell manufacturing processes has potent anti-multiple myeloma activity. J Immunother Cancer.
Citación estilo ChicagoGarrett, Tracy E., et al. "A BCMA-specific CAR T Cell Produced With Clinically Scalable Lentiviral and T Cell Manufacturing Processes Has Potent Anti-multiple Myeloma Activity." J Immunother Cancer 2015.
Cita MLAGarrett, Tracy E., et al. "A BCMA-specific CAR T Cell Produced With Clinically Scalable Lentiviral and T Cell Manufacturing Processes Has Potent Anti-multiple Myeloma Activity." J Immunother Cancer 2015.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.